211 related articles for article (PubMed ID: 23600735)
1. Chemical and preclinical studies on Hedyotis diffusa with anticancer potential.
Niu Y; Meng QX
J Asian Nat Prod Res; 2013; 15(5):550-65. PubMed ID: 23600735
[TBL] [Abstract][Full Text] [Related]
2. Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs.
Meng QX; Roubin RH; Hanrahan JR
J Ethnopharmacol; 2013 Jun; 148(1):229-38. PubMed ID: 23623820
[TBL] [Abstract][Full Text] [Related]
3. Characterization and identification of iridoid glucosides, flavonoids and anthraquinones in Hedyotis diffusa by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Liu EH; Zhou T; Li GB; Li J; Huang XN; Pan F; Gao N
J Sep Sci; 2012 Jan; 35(2):263-72. PubMed ID: 25940590
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the chemical constituents in herb of Hedyotis diffusa].
Zhang YY; Luo JB
Zhong Yao Cai; 2008 Apr; 31(4):522-4. PubMed ID: 18661823
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
Li YL; Zhang J; Min D; Hongyan Z; Lin N; Li QS
PLoS One; 2016; 11(4):e0151502. PubMed ID: 27064569
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
[TBL] [Abstract][Full Text] [Related]
7. Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice.
Ye JH; Liu MH; Zhang XL; He JY
Int J Mol Sci; 2015 Nov; 16(11):27252-69. PubMed ID: 26580602
[TBL] [Abstract][Full Text] [Related]
8. The Antitumor Constituents from Hedyotis Diffusa Willd.
Wang C; Zhou X; Wang Y; Wei D; Deng C; Xu X; Xin P; Sun S
Molecules; 2017 Nov; 22(12):. PubMed ID: 29189741
[TBL] [Abstract][Full Text] [Related]
9. 2-hydroxy-3-methylanthraquinone from Hedyotis diffusa Willd induces apoptosis in human leukemic U937 cells through modulation of MAPK pathways.
Wang N; Li DY; Niu HY; Zhang Y; He P; Wang JH
Arch Pharm Res; 2013 Jun; 36(6):752-8. PubMed ID: 23550028
[TBL] [Abstract][Full Text] [Related]
10. [Study on flavonoids from Hedyotis diffusa Willd].
Zhang H; Chen Y; Huang R
Zhong Yao Cai; 2005 May; 28(5):385-7. PubMed ID: 16131030
[TBL] [Abstract][Full Text] [Related]
11. Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.
Han X; Zhang X; Wang Q; Wang L; Yu S
Biomed Pharmacother; 2020 Oct; 130():110735. PubMed ID: 34321173
[TBL] [Abstract][Full Text] [Related]
12. Methylanthraquinone from Hedyotis diffusa WILLD induces Ca(2+)-mediated apoptosis in human breast cancer cells.
Liu Z; Liu M; Liu M; Li J
Toxicol In Vitro; 2010 Feb; 24(1):142-7. PubMed ID: 19686834
[TBL] [Abstract][Full Text] [Related]
13. Two new iridoid glucosides from Hedyotis diffusa.
Zhang Y; Chen Y; Fan C; Ye W; Luo J
Fitoterapia; 2010 Sep; 81(6):515-7. PubMed ID: 20080156
[TBL] [Abstract][Full Text] [Related]
14. Four anthraquinones from Hedyotis diffusa.
Huang WH; Yu SH; Li YB; Jiang JQ
J Asian Nat Prod Res; 2008; 10(9-10):887-9. PubMed ID: 18985502
[TBL] [Abstract][Full Text] [Related]
15. Effective 2D-RPLC/RPLC enrichment and separation of micro-components from Hedyotis diffusa Willd. and characterization by using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li C; Zhao Y; Guo Z; Zhang X; Xue X; Liang X
J Pharm Biomed Anal; 2014 Oct; 99():35-44. PubMed ID: 25061712
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-inducing effects of two anthraquinones from Hedyotis diffusa WILLD.
Shi Y; Wang CH; Gong XG
Biol Pharm Bull; 2008 Jun; 31(6):1075-8. PubMed ID: 18520033
[TBL] [Abstract][Full Text] [Related]
17. Two new anthraquinones from Hedyotis diffusa W.
Kang XD; Li X; Zhao CC; Mao Y
J Asian Nat Prod Res; 2008; 10(1-2):193-7. PubMed ID: 18253888
[TBL] [Abstract][Full Text] [Related]
18. Analyzing hedyotis diffusa mechanisms of action from the genomics perspective.
Hu CJ; He J; Li GZ; Fang PP; Xie JD; Ding YW; Mao YQ; Hu KF
Comput Methods Programs Biomed; 2019 Jun; 174():1-8. PubMed ID: 30442470
[TBL] [Abstract][Full Text] [Related]
19. Isolation, purification, structural characteristics, pharmacological activities, and combined action of Hedyotis diffusa polysaccharides: A review.
Zhang R; Ma C; Wei Y; Wang X; Jia J; Li J; Li K; Cao G; Yang P
Int J Biol Macromol; 2021 Jul; 183():119-131. PubMed ID: 33905802
[TBL] [Abstract][Full Text] [Related]
20. 2-Hydroxy-3-methylanthraquinone from Hedyotis diffusa WILLD induces apoptosis via alteration of Fas/FasL and activation of caspase-8 in human leukemic THP-1 cells.
Wang JH; Shu LH; Yang LL; Zhang M; He P
Arch Med Res; 2011 Oct; 42(7):577-83. PubMed ID: 22108623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
